Page 1095 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

24. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira 40. Yong D, Toleman MA, Giske CG, et al. Characterization of a new
M. Escherichia coli sequence type ST131 as the major cause metallo-beta-lactamase gene, bla(NDM-1), and a novel erythro-
of serious multidrug-resistant E. coli infections in the United mycin esterase gene carried on a unique genetic structure in
States. Clin Infect Dis. August 1, 2010;51(3):286-294. Klebsiella pneumoniae sequence type 14 from India. Antimicrob
25. Coelho A, Mora A, Mamani R, et al. Spread of Escherichia coli Agents Chemother. December 2009;53(12):5046-5054.
O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with 41. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence
high virulence gene content in Barcelona (Spain). J Antimicrob of a new antibiotic resistance mechanism in India, Pakistan,
Chemother. March 2011;66(3):517-526. and the UK: a molecular, biological, and epidemiological study.
26. Ito H, Arakawa Y, Ohsuka S, Wacharotayankun R, Kato N, Ohta M. Lancet Infect Dis. September 2010;10(9):597-602.
Plasmid-mediated dissemination of the metallo-beta-lactamase 42. Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage
gene blaIMP among clinically isolated strains of Serratia marces- of Enterobacteriaceae with NDM-1 carbapenemase at military
cens. Antimicrob Agents Chemother. April 1995;39(4):824-829. hospitals in Pakistan, and evaluation of two chromogenic
27. Vatopoulos A. High rates of metallo-beta-lactamase-producing media. J Antimicrob Chemother. July 25, 2011;66(10):2284-2294.
Klebsiella pneumoniae in Greece–a review of the current evi- 43. Lascols C, Hackel M, Marshall SH, et al. Increasing prevalence
dence. Euro Surveill. January 24, 2008;13(4). pii:8023. and dissemination of NDM-1 metallo-β-lactamase in India:
28. Zarkotou O, Pournaras S, Voulgari E, et al. Risk factors and data from the SMART study (2009). J Antimicrob Chemother.
outcomes associated with acquisition of colistin-resistant KPC- June 14, 2011;66(9):1992-1997.
producing Klebsiella pneumoniae: a matched case-control 44. Raghunath D. New metallo beta-lactamase NDM-1. Indian J
study. J Clin Microbiol. June 2010;48(6):2271-2274. Med Res. November 2010;132(5):478-481.
29. Chow JW, Shlaes DM. Imipenem resistance associated with the 45. Sarma JB, Bhattacharya PK, Kalita D, Rajbangshi M. Multidrug-
loss of a 40 kDa outer membrane protein in Enterobacter aero- resistant Enterobacteriaceae including metallo-beta-lactamase
genes. J Antimicrob Chemother. October 1991;28(4):499-504. producers are predominant pathogens of healthcare- associated
30. Ahmad M, Urban C, Mariano N, et al. Clinical characteris- infections in an Indian teaching hospital. Indian J Med Microbiol.
tics and molecular epidemiology associated with imipenem- January-March 2011;29(1):22-27.
resistant Klebsiella pneumoniae. Clin Infect Dis. August 1999;29 46. Alvarez Lerma F, Palomar M, Insausti J, Olaechea P, Alcala
(2):352-355. MA, Blanco A. Enterococcal infections in critically ill patients
31. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbape- admitted to ICU. Med Clin (Barc). September 13, 2003;121(8):
nem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem- 281-286.
resistant strain of Klebsiella pneumoniae. Antimicrob Agents 47. Fridkin SK, Edwards JR, Courval JM, et al. The effect of van-
Chemother. April 2001;45(4):1151-1161. comycin and third-generation cephalosporins on prevalence
32. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, of vancomycin-resistant enterococci in 126 U.S. adult intensive
Athanassopoulou P, Michalopoulos A. Outcome of infections care units. Ann Intern Med. August 7, 2001;135(3):175-183.
due to pandrug-resistant (PDR) Gram-negative bacteria. BMC 48. Murray BE. Vancomycin-resistant enterococcal infections.
Infect Dis. 2005;5:24. N Engl J Med. March 9, 2000;342(10):710-721.
33. Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative 49. Wong AH, Wenzel RP, Edmond MB. Epidemiology of bacteri-
bacteria: the dawn of the post-antibiotic era? Int J Antimicrob uria caused by vancomycin-resistant enterococci–a retrospec-
Agents. June 2007;29(6):630-636. tive study. Am J Infect Control. August 2000;28(4):277-281.
34. Antoniadou A, Kontopidou F, Poulakou G, et al. Colistin- 50. Zhanel GG, Laing NM, Nichol KA, et al. Antibiotic activity
resistant isolates of Klebsiella pneumoniae emerging in against urinary tract infection (UTI) isolates of vancomycin-
intensive care unit patients: first report of a multiclonal cluster. resistant enterococci (VRE): results from the 2002 North
J Antimicrob Chemother. April 2007;59(4):786-790. American Vancomycin Resistant Enterococci Susceptibility
35. Grundmann H, Livermore DM, Giske CG, et al. Carbapenem- Study (NAVRESS). J Antimicrob Chemother. September
non-susceptible Enterobacteriaceae in Europe: conclusions 2003;52(3):382-388.
from a meeting of national experts. Euro Surveill. November 18, 51. Kumar A, Roberts D, Wood K, et al. Duration of hypotension
2010;15(46). pii:19711. before initiation of effective antimicrobial therapy is the critical
36. Gaibani P, Ambretti S, Berlingeri A, et al. Rapid increase of car- determinant of survival in human septic shock. Crit. Care Med.
bapenemase-producing Klebsiella pneumoniae strains in a large 2006;34(6):1589-1596.
Italian hospital: surveillance period 1 March—30 September 52. Micek ST, Welch EC, Khan J, et al. Empiric combination anti-
2010. Euro Surveill. 2011;16(8). pii:19800. biotic therapy is associated with improved outcome against
37. Mezzatesta ML, Gona F, Caio C, et al. Outbreak of KPC-3- sepsis due to Gram-negative bacteria: a retrospective analysis.
producing, and colistin-resistant, Klebsiella pneumoniae infec- Antimicrob Agents Chemother. May 2010;54(5):1742-1748.
tions in two Sicilian hospitals. Clin Microbiol Infect. May 7, 53. Zhanel GG, DeCorby M, Laing N, et al. Antimicrobial-
2011;17(9):1444-1447. resistant pathogens in intensive care units in Canada: results
38. Toth A, Damjanova I, Puskas E, et al. Emergence of a colis- of the Canadian National Intensive Care Unit (CAN-ICU)
tin-resistant KPC-2-producing Klebsiella pneumoniae study, 2005-2006. Antimicrob Agents Chemother. April 2008;
ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis. July 52(4):1430-1437.
2010;29(7):765-769. 54. Stamm WE, McKevitt M, Counts GW. Acute renal infection
39. Elemam A, Rahimian J, Mandell W. Infection with panresistant in women: treatment with trimethoprim-sulfamethoxazole or
Klebsiella pneumoniae: a report of 2 cases and a brief review of ampicillin for two or six weeks. A randomized trial. Ann Intern
the literature. Clin Infect Dis. July, 15 2009;49(2):271-274. Med. March 1987;106(3):341-345.

Section05-O-ref.indd 2 1/20/2015 4:51:24 PM